Literature DB >> 8648694

The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface.

J C Mulloy1, R W Crownley, J Fullen, W J Leonard, G Franchini.   

Abstract

p12I is a small hydrophobic protein encoded by the human T-cell leukemia/lymphotropic virus type 1 (HTLV-1) that interacts with the 16-kDa component of the H+ vacuolar ATPase and cooperates with bovine papillomavirus 1 E5 oncoprotein in cell transformation. Just as an important step in E5 action appears to be its binding to the platelet-derived growth factor receptor, it was found that p12I binds specifically to both the beta and gamma(c) chains of the interleukin-2 receptor (IL-2R). The IL-2R beta and gamma(c) chains associated with p12I are endoglycosidase-H sensitive, suggesting that their interaction occurs in a pre-Golgi compartment. p12I stabilizes the immature forms of the IL-2R beta and gamma(c) chains and decreases their cell surface expression. The interactions of p12I with IL-2R beta and gamma(c) may have important implications in the immunosuppressive effect of HTLV-1 in vivo as well as in the ligand-independent HTLV-1-mediated T-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648694      PMCID: PMC190235     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.

Authors:  L Petti; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments.

Authors:  I J Koralnik; J Fullen; G Franchini
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 3.  The IL-2/IL-2 receptor system: a current overview.

Authors:  T Taniguchi; Y Minami
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

Review 4.  Structure, function, and activation of the erythropoietin receptor.

Authors:  H Youssoufian; G Longmore; D Neumann; A Yoshimura; H F Lodish
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

5.  Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein.

Authors:  L A Nilson; D DiMaio
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.

Authors:  M Noguchi; H Yi; H M Rosenblatt; A H Filipovich; S Adelstein; W S Modi; O W McBride; W J Leonard
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

7.  Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.

Authors:  G B Mills; N Arima; C May; M Hill; R Schmandt; J Li; N G Miyamoto; W C Greene
Journal:  Int Immunol       Date:  1992-11       Impact factor: 4.823

8.  Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.

Authors:  E Cesarman; A Chadburn; G Inghirami; G Gaidano; D M Knowles
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

9.  The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.

Authors:  D J Goldstein; T Andresson; J J Sparkowski; R Schlegel
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.

Authors:  S D Voss; P M Sondel; R J Robb
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  44 in total

1.  Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.

Authors:  J M Johnson; C Nicot; J Fullen; V Ciminale; L Casareto; J C Mulloy; S Jacobson; G Franchini
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.

Authors:  B Albrecht; N D Collins; M T Burniston; J W Nisbet; L Ratner; P L Green; M D Lairmore
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.

Authors:  Nancy Van Prooyen; Heather Gold; Vibeke Andresen; Owen Schwartz; Kathryn Jones; Frank Ruscetti; Stephen Lockett; Prabhakar Gudla; David Venzon; Genoveffa Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

4.  Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.

Authors:  Valerio W Valeri; Anna Hryniewicz; Vibeke Andresen; Kathy Jones; Claudio Fenizia; Izabela Bialuk; Hye Kyung Chung; Risaku Fukumoto; Robyn Washington Parks; Maria Grazia Ferrari; Christophe Nicot; Valentina Cecchinato; Frank Ruscetti; Genoveffa Franchini
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

5.  Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1.

Authors:  Risaku Fukumoto; Miroslav Dundr; Christophe Nicot; Anthony Adams; Valerio W Valeri; Lawrence E Samelson; Genoveffa Franchini
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

6.  Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells.

Authors:  Wei Ding; Björn Albrecht; Robert E Kelley; Natarajan Muthusamy; Seung-Jae Kim; Ruth A Altschuld; Michael D Lairmore
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission.

Authors:  Dustin Edwards; Risaku Fukumoto; Maria Fernanda de Castro-Amarante; Luiz Carlos Junior Alcantara; Bernardo Galvão-Castro; Robyn Washington Parks; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 8.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

9.  Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation.

Authors:  Wei Ding; Seung-Jae Kim; Amrithraj M Nair; Bindhu Michael; Kathleen Boris-Lawrie; Adam Tripp; Gerold Feuer; Michael D Lairmore
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.